Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks’ gestation

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875 · see citing works

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101 · see citing works

The Statistical Analysis of Failure Time Data

Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219 · see citing works

The Global Impact of Pre-eclampsia and Eclampsia

Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866 · see citing works

THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)

Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894 · see citing works

Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants

KHONG, T. Y., DE WOLF, F., ROBERTSON, W. B., & BROSENS, I. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07830.x · Cited by 1,591 · see citing works

A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS

Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413 · see citing works

The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369 · see citing works

Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy

Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J., & Giguère, Y. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,096 · see citing works

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial

Koopmans, C. M., Bijlenga, D., Groen, H., Vijgen, S. M. C., Aarnoudse, J. G., Bekedam, D. J., van den Berg, P. P., de Boer, K., Burggraaff, J. M., Bloemenkamp, K. W. M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60736-4 · Cited by 791 · see citing works

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668 · see citing works

Placental bed spiral arteries in the hypertensive disorders of pregnancy

Pijnenborg, R., Anthony, J., Davey, D. A., Rees, A., Tiltman, A. J., Vercruysse, L., & Assche, A. V. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb13450.x · Cited by 667 · see citing works

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

Akolekar, R., Syngelaki, A., Poon, L. C., Wright, D. E., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601 · see citing works

Make every mother and child count.

Spencer-Jones, J. (2005) · PubMed · Cited by 523 · see citing works

Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia

Chappell, L. C., Duckworth, S., Seed, P. T., Griffin, M., Myers, J., Mackillop, L. H., Simpson, N., Waugh, J. J. S., Anumba, D. O. C., Kenny, L. C., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003215 · Cited by 501 · see citing works

First-Trimester Prediction of Hypertensive Disorders in Pregnancy

Poon, L. C., Kametas, N. A., Maíz, N., Akolekar, R., & Nicolaides, K. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127977 · Cited by 465 · see citing works

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

Verlohren, S., Herraı̀z, I., Lapaire, O., Schlembach, D., Moertl, M. G., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 452 · see citing works

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

Roberge, S., Villa, P., Nicolaides, K. H., Giguère, Y., Vainio, M., Bakthi, A., Ebrashy, A., & Bujold, E. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000336662 · Cited by 380 · see citing works

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

Kumasawa, K., Ikawa, M., Kidoya, H., Hasuwa, H., Saito‐Fujita, T., Morioka, Y., Takakura, N., Kimura, T., & Okabe, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011293108 · Cited by 366 · see citing works

Turning the Pyramid of Prenatal Care

Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000324320 · Cited by 357 · see citing works

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Thadhani, R., Kisner, T., Hagmann, H., Boßung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034793 · Cited by 347 · see citing works

Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia

Li, Z., Zhang, Y., Jing, Y., Kapoun, A. M., Shao, Q., Kerr, I., Lam, A., O’Young, G., Sannajust, F. J., Stathis, P., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092098 · Cited by 258 · see citing works

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis

Kleinrouweler, C. E., Wiegerinck, M. M. J., Ris‐Stalpers, C., Bossuyt, P. M., van der Post, J., von Dadelszen, P., Mol, B. W., & Pajkrt, E. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03311.x · Cited by 251 · see citing works

A Competing Risks Model in Early Screening for Preeclampsia

Wright, D. E., Akolekar, R., Syngelaki, A., Poon, L. C., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000338470 · Cited by 235 · see citing works

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia

Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Kusanovic, J. P., Soto, E., Lam, J., Dong, Z., Than, N. G., Yeo, L., Hernandez‐Andrade, E. A., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.016 · Cited by 144 · see citing works

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

Chaiworapongsa, T., Romero, R. J., Savasan, Z. A., Kusanovic, J. P., Oggè, G., Soto, E., Dong, Z., Tarca, A. L., Bhatti, G., & Hassan, S. S. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.589932 · Cited by 139 · see citing works

Birthweight with Gestation and Maternal Characteristics in Live Births and Stillbirths

Poon, L. C., Volpe, N., Muto, B., Syngelaki, A., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000338655 · Cited by 123 · see citing works

Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast

Munaut, C., Lorquet, S., Péqueux, C., Blacher, S., Berndt, S., Frankenne, F., & Foidart, J. (2008) · Human Reproduction · doi:10.1093/humrep/den114 · Cited by 114 · see citing works

Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights

Bdolah, Y., Sukhatme, V. P., & Karumanchi, S. A. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.07.003 · Cited by 113 · see citing works

Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation

Torry, D., Mukherjea, D., Arroyo, J. A., & Torry, R. J. (2003) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(03)00048-0 · Cited by 102 · see citing works

Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights

Bdolah, Y., Sukhatme, V. P., & Karumanchi, S. A. (2004) · Seminars in Nephrology · doi:10.1016/s0270-9295(04)00125-1 · Cited by 90 · see citing works

Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

Sibiude, J., Guibourdenche, J., Dionne, M.-D., Ray, C. L., Anselem, O., Serreau, R., Goffinet, F., & Tsatsaris, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050208 · Cited by 79 · see citing works

Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation

Ohkuchi, A., Hirashima, C., Takahashi, K., Suzuki, H., Matsubara, S., & Suzuki, M. (2013) · Hypertension Research · doi:10.1038/hr.2013.95 · Cited by 42 · see citing works

Induction of Labor Versus Expectant Monitoring for Gestational Hypertension or Mild Preeclampsia After 36 Weeks of Gestation (HYPITAT): a Multicenter, Open-label Randomized Controlled Trial

Koopmans, C. M., Bijlenga, D., Groen, H. J., et al. (2010) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000386836.50750.06 · Cited by 39 · see citing works

Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation

Tayyar, A., Larroca, S. G., Poon, L. C., Wright, D. E., & Nicolaides, K. H. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000360792 · Cited by 29 · see citing works

Accuracy of Circulating Placental Growth Factor, Vascular Endothelial Growth Factor, Soluble fms-like Tyrosine Kinase-1, and Soluble Endoglin in the Prediction of Preeclampsia

Kleinrouweler, C. E., Wiegerinck, M. M. J., Ris‐Stalpers, C., et al. (2013) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000432382.59560.a1 · Cited by 28 · see citing works

Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity

Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253 · see citing works

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida

Phupong, V., Areeruk, W., Tantbírójn, P., & Lertkhachonsuk, R. (2020) · Hypertension in Pregnancy · doi:10.1080/10641955.2020.1745227 · Cited by 7 · see citing works

Anti-angiogenic Effect of Black Rice Bran (Oryza Sativa L. Sembada Hitam) on Soluble Fms-Like Tyrosine Kinase and Placental Growth Factor in Preeclampsia

Christanto, D. R., Mose, J. C., Yuniarti, T., et al. (2021) · Systematic Reviews in Pharmacy · Cited by 2 · see citing works

The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application

Lapaire, O., Shennan, A. H., & Stepan, H. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.04.009 · Cited by 62 · see citing works

Predictive Accuracy of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for Preeclampsia in Japan: A Systematic Review

Yamazaki, T., Cerdeira, A. S., Agrawal, S., Koh, I., Sugimoto, J., Vatish, M., & Kudo, Y. (2020) · Hypertension Research in Pregnancy · doi:10.14390/jsshp.hrp2020-012 · Cited by 3 · see citing works

The role of angiogenic factors in preeclampsia

Alasztics, B., Gullai, N., Molvarec, A., & Rigó, J. J. (2014) · Orvosi Hetilap · doi:10.1556/oh.2014.30042 · Cited by 9 · see citing works